Ascend Capital’s ICU Medical ICUI Stock Holding History

Ascend Capital’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-35,000	Closed	-$2.13M	–	195
2014 Q2	$2.13M	Sell	35,000 -120,000	-77%	-$7.08M	0.07%	155
2014 Q1	$9.28M	Buy	+155,000	New	+$9.55M	0.24%	109

Other funds holding ICUI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ascend Capital's ICUI Position: Q3 2014 in Review

Ascend Capital sold out of ICU Medical (ICUI) in Q3 2014, closing a stake of 35,000 shares — an estimated $2.13M sold.

Ascend Capital first reported a position in ICUI in Q1 2014 and held it in 2 quarters. The position peaked at $9.28M in Q1 2014. 173 funds tracked by Wall St. Rank hold ICUI as of Q3 2014.

Ascend Capital reported no remaining ICU Medical position as of Q3 2014 after selling out during the quarter.
Ascend Capital sold 35,000 ICU Medical shares in Q3 2014, an estimated $2.13M.
Ascend Capital first reported a position in ICU Medical in Q1 2014 and held it in 2 quarters.
Ascend Capital's ICU Medical position peaked at $9.28M in Q1 2014.
173 funds tracked by Wall St. Rank held ICU Medical as of Q3 2014.

Based on Ascend Capital's 13F filing for Q3 2014, filed 13 Nov 2014.